Israel's BrainStorm to begin advanced trial for ALS stem cell treatment

TEL AVIV, Dec 19 (Reuters) - Israel's BrainStorm Cell

Therapeutics said it is proceeding to a Phase 3

clinical trial for its adult stem cell treatment in patients

with amyotrophic lateral sclerosis (ALS).

Read more

BRIEF-Glenmark Pharma expects to launch 20 generic products annually in U.S.

* Says Glenmark expects to file 2025 ANDAs and launch 20

generic products annually in the U.S.

Source text: http://bit.ly/2hLg0qA

Further company coverage:

Read more

UPDATE 2-UK Stocks-Factors to watch on Dec. 19

Dec 19 (Reuters) - Britain's FTSE 100 index is seen opening up 10

points at 7,022 on Monday, according to financial bookmakers, with futures

up about 0.4 percent ahead of the cash market open.

Read more

BRIEF-Gilead says Japan's Ministry of Health, Labour and Welfare approves co's Vemlidy for patients with chronic Hepatitis B virus infection

* Gilead - Japan's Ministry of Health, Labour and Welfare

approves Gilead's Vemlidy for patients with chronic Hepatitis B

virus infection

Source text for Eikon:

Further company coverage:

Read more

BRIEF-UMC orders machinery equipment from Lam Research

* Says orders machinery equipment worth T$508.5 million

($15.91 million)

Read more

BRIEF-BlackBerry says no plans to move any BBM infrastructure to Indonesia

* BlackBerry says "there are no plans to move any BBM

infrastructure, including BBM servers located in Canada and

U.S., to Indonesia"

Source http://blck.by/2hKs4G3

Further company coverage:

Read more

BRIEF-Lupin launches generic drug, Vfend, in U.S.

* Lupin launches generic Vfend tablets and Vfend oral

suspension in the U.S.

Source text: http://bit.ly/2hPQA8s

Further company coverage:

Read more